1. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N, other NSABBP investigators: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowl Project P-1 study. J NCI 90: 1371-1388, 1998
2. Bilimoria MM, Assikis VJ, Jordan VC: Should adjuvant tamoxifen therapy be stopped at 5 years? Cancer J Sci Am 2: 140-150, 1996
3. Downset M, Lee K, Macaulay VM, Detre S, Rowlands M, Grimshaw R: The control and biological importance of intratumoral aromatase in breast cancer. J Ster Biochem Mol Biol 56: 145-150, 1996
4. Brodie AMH: Aromatase inhibitors in the treatment of breast cancer. J Ster Biochem Mol Biol 49: 281-287, 1994
5. Cole PA, Robinson CH: Mechanism and inhibition of cytochrome P-450 aromatase. J Med Chem 33(11): 2933-2942, 1990